Document Classification

Section Type: RESULTS

Text: In those 14 patients able to tolerate all forms of pharmacotherapy, HDL-C of 0. 89 + / - 0. 17 mmol/liter (34. 5 + / - 6. 5 mg/dl) increased by 15 %, to 1. 02 + / - 0. 18 mmol/liter (39. 7 + / - 7. 1 mg/dl), while taking gemfibrozil (1, 200 mg/day) ; by 35 %, to 1. 20 + / - 0. 21 mmol/liter (46. 5 + / - 8. 1 mg/dl), while taking NA (mean dose 2, 250 mg/day) ; and by 45 %, to 1. 29 + / - 0. 19 mmol/liter (50. 0 + / - 7. 5 mg/dl), while taking combination therapy of gemfibrozil plus NA (p < 0. 001 for all interventions as compared with baseline/washout ; p < 0. 005 NA vs. gemfibrozil ; p < 0. 001 combination therapy vs. gemfibrozil alone ; p = 0. 088 combination therapy vs. NA alone).